Home » Research Summaries » Search Results

Archives: Research Summaries

Indirect Treatment Comparison of Ravulizumab Versus Approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-Positive (AQP4-IgG+) Neuromyelitis Optica Spectrum Disorder (NMOSD) (P10-14.005)

Journal: Neurology; April 9, 2024

Author(s): Stacey Clardy, Sean Pittock, Orhan Aktas, Jin Nakahara, Noriko Isobe, Diego Centonze, Sami Fam, Adrian Kielhorn, Jeffrey Yu, Jeroen Jansen, and Ina Zhang

How does ravulizumab compare with other approved treatments for NMOSD?

Efficacy and safety of apheresis therapy in AQP4 antibody-positive NMOSD attack: A propensity score-matched cohort study

Journal: CNS Neuroscience & Therapeutics; May 24, 2024

Author(s): Yun Xu, Huabing Wang, Tian Song, Linlin Yin, Yajun Yao, Yuzhen Wei, Hengri Cong, Jiali Sun, Xinghu Zhang, De-Cai Tian

How safe and effective are plasma exchange and immunoadsorption for NMOSD attacks?

Attack phenotypes and disease course in pediatric MOGAD

Journal: Annals of Clinical and Translational Neurology; March 31, 2023

Author(s): Jonathan D. Santoro, Timothy Beukelman, Cheryl Hemingway, Suvi R. K. Hokkanen, Frank Tennigkeit, Tanuja Chitnis

Early symptoms and disease progression for MOGAD in children

Do Early Relapses Predict the Risk of Long-Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD?

Journal: Annals of Neurology; July 3, 2023

Author(s): Bo Chen, Enrique Gomez-Figueroa, Vyanka Redenbaugh, Anna Francis, Chanjira Satukijchai, Yan Wu, Silvia Messina, Mario Sa, Mark Woodhall, Friedemann Paul, Neil P. Robertson, Ming Lim, Evangeline Wassmer, Rachel Kneen, Saif Huda, Camilla Blain, Christopher Halfpenny, Cheryl Hemingway, Eoin O'Sullivan, Jeremy Hobart, Leonora K. Fisniku, Roswell J. Martin, Ruth Dobson, Sarah A. Cooper, Victoria Williams, Patrick Waters, John J. Chen, Sean J. Pittock, Sithara Ramdas, Maria Isabel Leite, Eoin P. Flanagan, Ruth Geraldes, Jacqueline Palace

Does an early relapse after the first episode increase the risk of a relapsing pattern of MOGAD?

Validation of the 2023 International Diagnostic Criteria for MOGAD in a Selected Cohort of Adults and Children

Journal: Neurology; June 13, 2024

Author(s): James A. Varley, Dimitrios Champsas, Timothy Prossor, Giuseppe Pontillo, Omar Abdel-Mannan, Zhaleh Khaleeli, Axel Petzold, Ahmed T. Toosy, Sachid A. Trip, Heather Wilson, Dermot H. Mallon, Cheryl Hemingway, Kshitij Mankad, Michael Kin Loon Chou Andrew J. Church, Melanie S. Hart, Michael P. Lunn, Wallace Brownlee, Yael Hacohen, and Olga Ciccarelli

Testing the validity of the 2023 International Diagnostic Criteria for MOGAD in a selected group of adults and children

Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria

Journal: The Lancet Neurology; March 1, 2023

Author(s): Brenda Banwell, Jeffrey L Bennett, Romain Marignier, Ho Jin Kim, Fabienne Brilot, Eoin P Flanagan, Sudarshini Ramanathan, Patrick Waters, Silvia Tenembaum, Jennifer S Graves, Tanuja Chitnis, Alexander U Brandt, Cheryl Hemingway, Rinze Neuteboom, Lekha Pandit, Markus Reindl, Albert Saiz, Douglas Kazutoshi Sato, Kevin Rostasy, Friedemann Paul, Sean J Pittock, Kazuo Fujihara, Jacqueline Palace

International consensus diagnostic criteria for MOGAD

Efficacy and safety of rituximab in myelin oligodendrocyte glycoprotein antibody-associated disorders compared with neuromyelitis optica spectrum disorder: a systematic review and meta-analysis

Journal: Journal of Neurology, Neurosurgery, and Psychiatry; January 1, 2023

Author(s): Gregorio Spagni, Bo Sun, Gabriele Monte, Elia Sechi, Raffaele Iorio, Amelia Evoli, Valentina Damato

How effective is rituximab in MOGAD compared to NMOSD?

Non‐demyelinating disorders mimicking and misdiagnosed as NMOSD: a literature review

Journal: European Journal of Neurology; July 11, 2023

Author(s): Pietro Zara, Alessandro Dinoto, Sara Carta, Valentina Floris, Davide Turilli, Adrian Budhram, Sergio Ferrari, Stefania Milia, Paolo Solla, Sara Mariotto, Eoin P. Flanagan, A. Sebastian Lopez Chiriboga, Elia Sechi

Non-demyelinating disorders that might be misdiagnosed as NMOSD

The neuro-ophthalmological manifestations of NMOSD and MOGAD—a comprehensive review

Journal: Eye; March 16, 2023

Author(s): Negar Moheb, John J. Chen

Features of optic neuritis and associated clinical signs in NMOSD and MOGAD

Characterization of disease severity and stability in NMOSD: a global clinical record review with patient interviews

Journal: Neurology and Therapy; February 24, 2023

Author(s): Marco Capobianco, Marius Ringelstein, Carly Welsh, Patricia Lobo, Gabrielle deFiebre, Marco Lana-Peixoto, Jiawei Wang, Ju-Hong Min & Dean M. Wingerchuk

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.